Instil Bio Reports Q4 Loss; EPS Improves Compared to Last Year

Instil Bio, Inc. reported a fourth-quarter loss of $11.90 million. Despite the loss, the EPS improved to -$1.82, up from -$1.99 in the previous year, indicating a slight positive trend.

Date: 04-03-2025

AI Rating: 5

Earnings per Share (EPS): Instil Bio reported an EPS of -$1.82 for the fourth quarter, an improvement from -$1.99 year-over-year. While the company continues to incur losses, the reduction in the loss per share is a sign of better operational performance compared to last year.

Net Income: The company reported a net loss of -$11.90 million, a slight improvement over the previous year's loss of -$12.93 million. This decline in the net loss may instill some confidence among investors regarding the company's efforts to reduce its losses.

The report does not provide details about revenue growth, profit margins, free cash flow, or return on equity, thus limiting a comprehensive evaluation of the company's financial health. Overall, while the company is still facing challenges with losses, the decreasing EPS shows steps toward recovery.

Stocks: TIL